Uni-Bio Science Group Limited (HKG:0690)
0.1150
+0.0010 (0.88%)
At close: Feb 13, 2026
Uni-Bio Science Group Market Cap
Uni-Bio Science Group has a market cap or net worth of 686.69 million as of February 13, 2026. Its market cap has increased by 85.48% in one year.
Market Cap
686.69M
Enterprise Value
605.38M
Revenue
589.59M
Ranking
n/a
PE Ratio
7.61
Stock Price
0.12
Market Cap Chart
Since November 12, 2001, Uni-Bio Science Group's market cap has increased from 1.02M to 686.69M, an increase of 67,223.79%. That is a compound annual growth rate of 30.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 686.69M | - |
| Dec 31, 2025 | 686.69M | 91.67% |
| Dec 31, 2024 | 358.27M | -20.75% |
| Dec 29, 2023 | 452.07M | -1.35% |
| Dec 30, 2022 | 458.26M | -14.08% |
| Dec 31, 2021 | 533.38M | -27.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CANbridge Pharmaceuticals | 1.50B |
| Shanghai Bio-heart Biological Technology | 1.45B |
| Wuhan YZY Biopharma | 1.40B |
| Kintor Pharmaceutical | 1.38B |
| Beijing Biostar Pharmaceuticals | 1.33B |
| 3D Medicines | 1.13B |
| Brii Biosciences | 1.11B |
| Transcenta Holding | 1.06B |